Feasibility Open Label Study Evaluating the Use of Process-Instructed Self Neuro-Modulation (PRISM) for Attention Deficit/Hyperactivity Disorder(ADHD)

Brief description of study

This is a single-arm, open-label feasibility study. A maximum of 15 participants will be enrolled. All participants will undergo a novel neurofeedback intervention, targeting down-regulation of deep limbic structures, specifically the amygdalae. Participants will complete 15 neurofeedback sessions delivered twice weekly over 8 consecutive weeks. The intervention will be delivered via the PRISM platform.

Clinical Study Identifier: s20-01086
ClinicalTrials.gov Identifier: NCT04640766

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.